Диссертация (1154749), страница 21
Текст из файла (страница 21)
1466-1467.54.Fan L.L. The diagnostic value of bronchalveolar lavage in immunocomplement children withchronic diffuse pulmonary infiltrates / L.L. Fan, M.C. Lung, J.S. Wagener // Pediatr Pulmonol. – 1997.– № 23 (1). – Р. 8-13.55.Flamein J. Molecular and cellular characteristics of ABCA3 mutations associated with diffuseparenchymal lung diseases in children / J.
Flamein, L. Riffault, C. Muselet-Charlier, et al. // HumanMol Genet. – 2012. – № 21. – Р. 765-775.10656.Gabbay E. Pulmonary arterial hypertension (PAH) is an uncommon cause of pulmonaryhypertension (PH) in an unselected population: the Armadable echocardiography study / E. Gabbay,W. Yeow, D. Playford // Am J Resp Crit Care Med. – 2007. – № 175. – Р.
713.57.Garcia-Peña P. HRCT in children: technique and indications / P. Garcia-Peña, J. Lucaya // EurRadiol. – 2004. – № 14 (4). – Р. 13-30.58.Gasser S.W. Pathogenesis of interstitial disease in children and adult / S.W. Gasser, W.D.Hardie, J.S. Hagood // Pediatric Allergy, Immunology, and Pulmonology. – 2010. – № 23 (1). – Р. 914.59.Gewitz M.H.
Cor pulmonale – Pulmonary heart disease / G.C. Emmanoulides, H.D. Allen,T.A. Riemenschneider, H.P. Gutgesel (eds) // Moss and Adams’Heart Disease in Infants, Children andAdolescents, Icluding the Fetus and Young Adult. 5th ed. Baltimore, Williams & Wilkins. – 1994. – P.345-368.60.Ghandourah H. Bronchiolitis obliterans organising pneumonia associated with anticonvulsanthypersensitivity syndrome induced by lamotrigine / H. Ghandourah, S. Bhandal, M.A.
Brundler, M.Noseworthy // BMJ Case Rep. – 2016.61.Gomes V.C. Diagnostic criteria and follow-up in neuroendocrine cell hyperplasia of infancy: acase series / V.C. Gomes, M.C. Silva, J.H. Maia Filho, et al. // J Bras Pneumol. – 2013. – № 39 (5). –Р. 569-578.62.Gonzalez O.R. Postnatal development of the cystic lung lesion of Down syndrome: suggestionthat the cause is reduced formation of peripheral air spaces / O.R. Gonzalez, I.G. Gomez, A.L.Recalde, B.H. Landing // Pediatr Pathol. – 1991. – № 11.
– Р. 623-633.63.Griese M. Incidence and classification of pediatric diffuse parenchymal lung diseases inGermany / M. Griese, M. Haug, F. Brasch, et al. // Orphanet J Rare Dis. – 2009. – № 4. – Р. 26.64.Grossman H. Neonatal focal hyperaeration of the lungs (Wilson-Mikity syndrome) / H.Grossman, W.E. Berdon, A. Mizrahi, D.H. Baker // Radiology. – 1965.
– № 85. – P. 409-417.65.Guillerman R.P. Imaging of Childhood Interstitial Lung Disease / R.P. Guillerman // PediatricAllergy, Immunology, and Pulmonology. – 2010. – № 23 (1). – Р. 43-69.66.Guillot L. NKX2-1 mutations leading to surfactant protein promoter dysregulation causeinterstitial lung disease in Brain-Lung-Thyroid Syndrome / L. Guillot, A.
Carre, G. Szinnai, et al. //Hum Mutat. – 2010. – № 31. – Р. 1146-1162.67.Hacking D. Idiopathic pulmonary fibrosis in infants: good prognosis with conservativemanagement / D. Hacking, R. Smyth, N. Shaw, et al. // Arch Dis Child. – 2000. – № 83. – Р. 152–157.68.Hamvas A. Heterogeneous pulmonary phenotypes associated with mutations in the thyroidtranscription factor gene NKX2-1 / A.
Hamvas, R.R. Deterding, S.E. Wert, et al // Chest. – 2013. – №144. – Р. 794-804.10769.Hamvas A. Lung transplantation for treatment of infants with surfactant protein B deficiency /A. Hamvas, L.M. Nogee, G.B. Mallory, et al. // J Pediatr. – 1997. – № 130. – Р. 231–239.70.Hansmann G. Treatment of children with pulmonary hypertension. Expert consensus statementon the diagnosis and treatment of paediatric pulmonary hypertension / G.
Hansmann, C. Apitz // Heart.– 2016. – № 102 (2). – Р. ii67-85.71.Helton K. Bronchiolitis obliterans-organizing pneumonia (BOOP) in children with malignantdisease / K. Helton, J. Kuhn, B. Fletcher et al. // Pediatr. Radiol. – 1992. – № 22 (4). – Р. 270-274.72.Hodgman J.E. Chronic respiratory distress in the premature infant. Wilson-Mikity syndrome /J.E. Hodgman, V.G. Mikity, D. Tatter, R.S. Cleland // Pediatrics. – 1969. – № 44 (2). – Р. 179-195.73.Hoepker А. Wilson–Mikity Syndrome: Updated Diagnostic Criteria Based on Nine Cases and aReview of the Literature / А.
Hoepker, М. Seear, А. Petrocheilou, et al. // Pediatric Pulmonology. –2008. – № 43. – Р. 1004-1012.74.Huddleston C.B. Lung transplantation in very young infants / C.B. Huddleston, S.C. Sweet,G.B. Mallory, et al. // J Thorac Cardiovasc Surg. – 1999. – № 118 (5). – Р. 796-804.75.International classification of diseases. ICD-10-CM Diagnosis Codes [электронный ресурс] //URL: www.icd10data.com/ICD10CM/Codes/J00-J99 (дата обращения 20.12.2016).76.Janney C.G.
Congenital alveolar capillary dysplasia – an unusual cause of respiratory distressin the newborn / C.G. Janney, F.B. Askin, C. Kuhn // Am J ClinPathol. – 1981. – № 76. – Р. 722-727.77.Jeune M. Dystrophie thoracique asphyxiante de caractère familial / M. Jeune, C. Béraud, R.Carron // Arch Fr Pediatr. – 1955. – № 12. – Р. 886-891.78.Kannan T. Fatal outcomes in family transmission of Mycoplasma pneumonia / T. Kannan, R.Hardy, J. Coalson, et al. // CID. – 2012.
– № 54. – Р. 225-231.79.Katzenstein A.-L.A. Chronic pneumonitis of infancy: a unique form of interstitial lung diseaseoccurring in early childhood / A.-L.A. Katzenstein, L.P. Gordon, M. Oliphant, P.T. Swender // Am JSurg Pathol. – 1995. – № 19. – Р. 439-447.80.Kerby G.S. Abnormal infant pulmonary function in young children with neuroendocrine cellhyperplasia of infancy / G.S. Kerby, B.D.
Wagner, J. Popler, et al. // Pediatr Pulmonol. – 2013. – № 48(10). – Р. 1008–1015.81.Kerem E. Sequential pulmonary function measurements during treatment of infantile chronicinterstitial pneumonitis / E. Kerem, L. Bentur, S. England, et al. // J Pediatr. – 1990. – № 116. – Р. 6167.82.Knyazhitskiy A. Beneficial response to macrolide antibiotic in a patient with desquamativeinterstitial pneumonia refractory to corticosteroid therapy / A.
Knyazhitskiy, R.G. Masson, R. Corkey,J. Joiner // Chest. – 2008. – № 134 (1). – Р. 185-187.10883.Kornum J.B. The incidence of interstitial lung disease 1995-2005: a Danish nationwidepopulation-based study. / J.B. Kornum, S. Christensen, M. Grijota, et al. // BMC Pulm Med. – 2008. –№ 8.
– Р. 24.84.Kurland G. An official American Thoracic Society clinical practice guideline: classification,evaluation, and management of childhood interstitial lung disease in infancy / G. Kurland, R.R.Deterding, J.S. Hagood, et al. // Am J Respir Crit Care Med. – 2013. – № 188 (3). – Р. 376-394.85.Langston C. Diffuse lung disease in infancy: a proposed classification applied to 259 diagnosticbiopsies / C. Langston, M.K.
Dishop // Pediatr Dev Pathol. – 2009. – № 12 (6). – Р. 421-437.86.Lee E.Y. Interstitial lung disease in infants: new classification system, imaging technique,clinical presentation and imaging findings / E.Y. Lee // Pediatr Radiol. – 2013. – № 43. – Р. 3-13.87.Lettieri C.J. Prevalence and outcomes of pulmonary arterial hypertension in advancedidiopathic pulmonary fibrosis / C.J. Lettieri, S.D. Nathan, S.D. Barnett, et al. // Chest. – 2006. – №129. – Р. 746-752.88.Liu J.R. Bronchiolitis obliterans organizing pneumonia due to gastroesophageal reflux / J.R.Liu, X.F. Xu, C.J.
Zhou, et al. // Pediatrics. – 2015. – № 135 (6). – Р. e1510-1513.89.Lukkarinen H. Neuroendocrine cell hyperplasia of infancy: a prospective follow up of ninechildren / H. Lukkarinen, A. Pelkonen, J. Lohi, et al. // Arch Dis Child. – 2013. – № 98. – Р. 141-144.90.Lynch D.A.
Pediatric diffuse lung disease: diagnosis and classification using high-resolutionCT / D.A. Lynch, T. Hay, J.D. Jr Newell, et al. // Am J Roentgenol. – 1999. – № 173 (3). – Р. 713-718.91.MacDonald S. Insights from HRCT: how they affect the management of diffuse parenchymallung disease / S. MacDonald, N.L. Müller // Semin Respir Crit Care Med. – 2003. – № 24.
– Р. 357364.92.Mallory G.B. Paediatric lung transplantation / G.B. Mallory, T.L. Spray // Eur Respir J. – 2004.– № 24 (5). – Р. 839-845.93.Marmor M.F. Revised recommendations on screening for chloroquine and hydroxychloroquineretinopathy / M.F. Marmor, U. Kellner, T.Y. Lai, et al. // Ophthalmology. – 2011. – № 118 (2). – Р.415-422.94.Martin A. Langerhans cell histiocytosis: 23 years’ paediatric experience highlights severe long-term sequelae / A. Martin, S. Macmillan, D. Murphy, R. Carachi // Scott.
Med. J. – 2014. – № 59 (3). –Р. 149-157.95.Mayell S.J. Management of infants on home oxygen / S.J. Mayell, G. Harrison, B.J. Shaw //Infant. – 2006. – № 2 (4). – Р. 147-151.96.Mayo J.R. CT evaluation of diffuse infiltrative lung disease: dose considerations and optimaltechnique / J.R. Mayo // J Thorac Imaging. – 2009. – № 24. – Р. 252-259.10997.MuneuchiJ.Pulmonaryarterialhypertensionassociatedwith bronchopulmonarydysplasia and congenital heart disease in preterm infants.
A case report of a preterm infant withrecurrent pulmonary hypertension after corrective cardiac surgery and review of the literature / J.Muneuchi, A. Kuraoka, M. Watanabe, et al. // Int Heart J. – 2015. – № 56. – Р. 22-25.98.Muthialu N. One-stage sequential bilateral thoracic expansion for asphyxiating thoracicdystrophy (Jeune syndrome) / N.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
